Abstract

Objective: To assess the impact of the NIH CTSA program on patient enrollment in clinical trials sponsored/collaborated by CTSA consortium institutions. Material and Methods: Using publicly available clinical trial data at ClinicalTrials.gov, we identify positive trend changes in the number of patients enrolled in clinical trials performed at CTSA consortium institutions over the years before and after their respective CTSA award dates. CTSA consortium institutions were matched with similar non-CTSA institutions. Results: As compared to matched non-CTSA institutions CTSA consortium sites noted an increase in patient enrollment after the CTSA awards. In particular, we detected a change-point, where a new enrollment trend emerged, 338 days after the CTSA award. No such trend was noted over the same period in the non-CTSA institutions. Conclusion: Our analysis provides evidence that the NIH CTSA funding program made a positive impact on patient enrollment.

Original languageEnglish (US)
Pages (from-to)196-200
Number of pages5
JournalClinical and Translational Science
Volume6
Issue number3
DOIs
StatePublished - Jun 1 2013

Fingerprint

Clinical Trials

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{7e066021dd484916a566b5c9c3063462,
title = "Assessing the impact of the NIH ctsa program on institutionally sponsored clinical trials",
abstract = "Objective: To assess the impact of the NIH CTSA program on patient enrollment in clinical trials sponsored/collaborated by CTSA consortium institutions. Material and Methods: Using publicly available clinical trial data at ClinicalTrials.gov, we identify positive trend changes in the number of patients enrolled in clinical trials performed at CTSA consortium institutions over the years before and after their respective CTSA award dates. CTSA consortium institutions were matched with similar non-CTSA institutions. Results: As compared to matched non-CTSA institutions CTSA consortium sites noted an increase in patient enrollment after the CTSA awards. In particular, we detected a change-point, where a new enrollment trend emerged, 338 days after the CTSA award. No such trend was noted over the same period in the non-CTSA institutions. Conclusion: Our analysis provides evidence that the NIH CTSA funding program made a positive impact on patient enrollment.",
author = "Guodong Liu and Gang Chen and Lawrence Sinoway and Arthur Berg",
year = "2013",
month = "6",
day = "1",
doi = "10.1111/cts.12029",
language = "English (US)",
volume = "6",
pages = "196--200",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "3",

}

Assessing the impact of the NIH ctsa program on institutionally sponsored clinical trials. / Liu, Guodong; Chen, Gang; Sinoway, Lawrence; Berg, Arthur.

In: Clinical and Translational Science, Vol. 6, No. 3, 01.06.2013, p. 196-200.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessing the impact of the NIH ctsa program on institutionally sponsored clinical trials

AU - Liu, Guodong

AU - Chen, Gang

AU - Sinoway, Lawrence

AU - Berg, Arthur

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Objective: To assess the impact of the NIH CTSA program on patient enrollment in clinical trials sponsored/collaborated by CTSA consortium institutions. Material and Methods: Using publicly available clinical trial data at ClinicalTrials.gov, we identify positive trend changes in the number of patients enrolled in clinical trials performed at CTSA consortium institutions over the years before and after their respective CTSA award dates. CTSA consortium institutions were matched with similar non-CTSA institutions. Results: As compared to matched non-CTSA institutions CTSA consortium sites noted an increase in patient enrollment after the CTSA awards. In particular, we detected a change-point, where a new enrollment trend emerged, 338 days after the CTSA award. No such trend was noted over the same period in the non-CTSA institutions. Conclusion: Our analysis provides evidence that the NIH CTSA funding program made a positive impact on patient enrollment.

AB - Objective: To assess the impact of the NIH CTSA program on patient enrollment in clinical trials sponsored/collaborated by CTSA consortium institutions. Material and Methods: Using publicly available clinical trial data at ClinicalTrials.gov, we identify positive trend changes in the number of patients enrolled in clinical trials performed at CTSA consortium institutions over the years before and after their respective CTSA award dates. CTSA consortium institutions were matched with similar non-CTSA institutions. Results: As compared to matched non-CTSA institutions CTSA consortium sites noted an increase in patient enrollment after the CTSA awards. In particular, we detected a change-point, where a new enrollment trend emerged, 338 days after the CTSA award. No such trend was noted over the same period in the non-CTSA institutions. Conclusion: Our analysis provides evidence that the NIH CTSA funding program made a positive impact on patient enrollment.

UR - http://www.scopus.com/inward/record.url?scp=84878976769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878976769&partnerID=8YFLogxK

U2 - 10.1111/cts.12029

DO - 10.1111/cts.12029

M3 - Article

C2 - 23751024

AN - SCOPUS:84878976769

VL - 6

SP - 196

EP - 200

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 3

ER -